» Articles » PMID: 34696383

HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2021 Oct 26
PMID 34696383
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

To minimize immune responses against infected cells, HIV-1 has evolved different mechanisms to limit the surface expression of its envelope glycoproteins (Env). Recent observations suggest that the binding of certain broadly neutralizing antibodies (bNAbs) targeting the 'closed' conformation of Env induces its internalization. On the other hand, non-neutralizing antibodies (nNAbs) that preferentially target Env in its 'open' conformation, remain bound to Env on the cell surface for longer periods of time. In this study, we attempt to better understand the underlying mechanisms behind the differential rates of antibody-mediated Env internalization. We demonstrate that 'forcing' open Env using CD4 mimetics allows for nNAb binding and results in similar rates of Env internalization as those observed upon the bNAb binding. Moreover, we can identify distinct populations of Env that are differentially targeted by Abs that mediate faster rates of internalization, suggesting that the mechanism of antibody-induced Env internalization partially depends on the localization of Env on the cell surface.

Citing Articles

HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.

Prevost J, Medjahed H, Vezina D, Chen H, Hahn B, Smith 3rd A Viruses. 2021; 13(11).

PMID: 34835042 PMC: 8625184. DOI: 10.3390/v13112236.

References
1.
Zhang S, Nguyen H, Ding H, Wang J, Zou S, Liu L . Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions. J Virol. 2020; 95(3). PMC: 7925103. DOI: 10.1128/JVI.01369-20. View

2.
Chew H, de Lima P, Gonzalez Cruz J, Banushi B, Echejoh G, Hu L . Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies. Cell. 2020; 180(5):895-914.e27. DOI: 10.1016/j.cell.2020.02.019. View

3.
Castillo-Menendez L, Witt K, Espy N, Princiotto A, Madani N, Pacheco B . Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers. J Virol. 2018; 92(12). PMC: 5974486. DOI: 10.1128/JVI.00277-18. View

4.
Chen J, Park J, Kirk S, Chen H, Li X, Lippincott D . Development of an Effective Scalable Enantioselective Synthesis of the HIV-1 Entry Inhibitor BNM-III-170 as the Bis-Trifluoroacetate Salt. Org Process Res Dev. 2020; 23(11):2464-2469. PMC: 7531044. DOI: 10.1021/acs.oprd.9b00353. View

5.
Popik W, Alce T, Au W . Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol. 2002; 76(10):4709-22. PMC: 136131. DOI: 10.1128/jvi.76.10.4709-4722.2002. View